Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Gabe Fernandez who wrote (1007)	2/17/2000 6:38:00 PM
From: David Israel-Rosen	Read Replies (1) \| Respond to of 1386

Gabe and everyone, look at BPUR I bought that stock in a private placement 10 years ago at $2 a share. They went public last summer at 14 and than went down to 6 by year end. Than by late January they traded at 54 than 24 and now they trade at 35... ...i think that pars pipeline and prospects are better...i think that once the street DISCOVERS the results the stock just might fly in as irrational way as it was so LOW for so long...I feel that we just might experience a BPUR like chart here with pars... For myself, I think that it will take 25 a share to purchase control of Pars today...